The EGFR or HER2 positive breast cancer cell lines MDA-MB-468 and SK-BR-3, respectively, were chosen as model systems to evaluate the role of sialic acid on tumor cell killing by PMN. The gene discussed is EGFR; the disease is breast carcinoma.